159 related articles for article (PubMed ID: 3012393)
1. Chronic estradiol treatment decreases angiotensin II receptor density in the anterior pituitary gland and adrenal cortex but not in the mesenteric artery.
Carrière PD; De Léan A; Gutkowska J; Genest J; Cantin M
Neuroendocrinology; 1986; 43(1):49-56. PubMed ID: 3012393
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II (AII) and adrenocorticotropin release: modulation by estradiol of the AII biological activity and binding characteristics in anterior pituitary dispersed cells.
Spinedi E; Herrera L; Chisari A
Endocrinology; 1988 Jul; 123(1):641-6. PubMed ID: 2838267
[TBL] [Abstract][Full Text] [Related]
3. Estrogens directly down-regulate receptors for angiotensin II in anterior pituitary cell culture without decreasing target cell responsiveness.
Carrière PD; De Léan A; Gutkowska J; Cantin M
Endocrinology; 1986 Jul; 119(1):429-31. PubMed ID: 3013596
[TBL] [Abstract][Full Text] [Related]
4. Evidence for the presence and characterization of angiotensin II receptors in rat anterior pituitary membranes.
Mukherjee A; Kulkarni P; McCann SM; Negro-Vilar A
Endocrinology; 1982 Feb; 110(2):665-7. PubMed ID: 6276145
[TBL] [Abstract][Full Text] [Related]
5. Effects of 17 beta-estradiol on angiotensin II receptors and prolactin release in cultured pituitary cells.
Platia MP; Catt KJ; Aguilera G
Endocrinology; 1986 Dec; 119(6):2768-72. PubMed ID: 3780551
[TBL] [Abstract][Full Text] [Related]
6. Receptor binding interactions of the angiotensin II antagonist, 125I-[sarcosine1,leucine8]angiotensin II, with mammalian brain and peripheral tissues.
Bennett JP; Snyder SH
Eur J Pharmacol; 1980 Oct; 67(1):11-25. PubMed ID: 6252019
[TBL] [Abstract][Full Text] [Related]
7. Estradiol attenuates angiotensin-induced aldosterone secretion in ovariectomized rats.
Roesch DM; Tian Y; Zheng W; Shi M; Verbalis JG; Sandberg K
Endocrinology; 2000 Dec; 141(12):4629-36. PubMed ID: 11108277
[TBL] [Abstract][Full Text] [Related]
8. Regulation of receptor binding interactions of 125I-angiotensin II and 125I-[sarcosine1,leucine8]angiotensin II, an angiotensin antagonist, by sodium ion.
Bennett JP; Snyder SH
Eur J Pharmacol; 1980 Oct; 67(1):1-10. PubMed ID: 6252018
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of the nonpeptide angiotensin II receptor antagonist, U-97018.
Kushida H; Nomura S; Morita O; Harasawa Y; Suzuki M; Nakano M; Ozawa K; Kunihara M
J Pharmacol Exp Ther; 1995 Sep; 274(3):1042-53. PubMed ID: 7562467
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II receptor subtypes and biological responses in the adrenal cortex and medulla.
Balla T; Baukal AJ; Eng S; Catt KJ
Mol Pharmacol; 1991 Sep; 40(3):401-6. PubMed ID: 1654513
[TBL] [Abstract][Full Text] [Related]
11. Chronic estrogen treatment reduces angiotensin II receptors in the anterior pituitary.
Chen FM; Printz MP
Endocrinology; 1983 Oct; 113(4):1503-10. PubMed ID: 6617583
[TBL] [Abstract][Full Text] [Related]
12. Different types of receptor interaction of peptide and nonpeptide angiotensin II antagonists revealed by receptor binding and functional studies.
Wienen W; Mauz AB; Van Meel JC; Entzeroth M
Mol Pharmacol; 1992 Jun; 41(6):1081-8. PubMed ID: 1614410
[TBL] [Abstract][Full Text] [Related]
13. Effect of aldosterone on vascular angiotensin II receptors in the rat.
Schiffrin EL; Franks DJ; Gutkowska J
Can J Physiol Pharmacol; 1985 Dec; 63(12):1522-7. PubMed ID: 3006895
[TBL] [Abstract][Full Text] [Related]
14. Estrogen effects on angiotensin receptors are modulated by pituitary in female rats.
Douglas JG
Am J Physiol; 1987 Jan; 252(1 Pt 1):E57-62. PubMed ID: 3812674
[TBL] [Abstract][Full Text] [Related]
15. In vitro pharmacology of a nonpeptidic angiotensin II receptor antagonist, SC-51316.
Olins GM; Corpus VM; McMahon EG; Palomo MA; Schuh JR; Blehm DJ; Huang HC; Reitz DB; Manning RE; Blaine EH
J Pharmacol Exp Ther; 1992 Jun; 261(3):1037-43. PubMed ID: 1602371
[TBL] [Abstract][Full Text] [Related]
16. Stimulatory or inhibitory effects of angiotensin II upon LH secretion in ovariectomized rats: a function of gonadal steroids.
Steele MK; Gallo RV; Ganong WF
Neuroendocrinology; 1985 Mar; 40(3):210-6. PubMed ID: 3990909
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of the angiotensin receptor negatively coupled with adenylate cyclase in rat anterior pituitary gland.
Marie J; Gaillard RC; Schoenenberg P; Jard S; Bockaert J
Endocrinology; 1985 Mar; 116(3):1044-50. PubMed ID: 2982569
[TBL] [Abstract][Full Text] [Related]
18. Analysis of angiotensin II receptor subtypes in individual rat brain nuclei.
Rowe BP; Saylor DL; Speth RC
Neuroendocrinology; 1992 May; 55(5):563-73. PubMed ID: 1584339
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of angiotensin II- and III-induced aldosterone release by prostaglandin synthesis inhibitors.
Campbell WB; Gomez-Sanchez CE; Adams BV; Schmitz JM; Itskovitz HD
J Clin Invest; 1979 Dec; 64(6):1552-7. PubMed ID: 500824
[TBL] [Abstract][Full Text] [Related]
20. Angiotensins II and IV stimulate the rat anterior pituitary cell proliferation independently of the AT1 receptor subtype.
Ptasinska-Wnuk D; Kunert-Radek J; Pawlikowski M
Neuro Endocrinol Lett; 2003 Dec; 24(6):397-400. PubMed ID: 15073563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
